July 31, 2014 10:51 PM ET

Healthcare Equipment and Supplies

Company Overview of Clarimedix, Inc.

Executive Profile

Jack De La Torre M.D., Ph.D.

Member of Alzheimer’S Disease Scientific Advisory Board, Clarimedix, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. Jack De La Torre, M.D., Ph.D. serves as the Member of Alzheimer’S Disease Scientific Advisory Board at Clarimedix, Inc. Dr. De La Torre is a leading authority in the field of Alzheimer’s disease (AD). In 1993, he first advanced the concept of AD as a vascular disorder with neurodegenerative consequences in a series of papers that culminated in the CATCH (critically-attained threshold of cerebral hypoperfusion) hypothesis of AD. Dr. de la Torre has edited 7 major ...

Corporate Headquarters

12635 East Montview Boulevard
Aurora, Colorado 80010

United States

Phone: --
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

BS
American University
PhD
University of Geneva
MD
Universidad Complutense de Madrid

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Clarimedix, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.